ReviewImmunoTargets and therapy2024

Immune Checkpoint Inhibitor Combined with Antiangiogenic Agent Synergistically Improving the Treatment Efficacy for Solid Tumors.

Yong Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.